TLSI
TriSalus Life Sciences, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$5.00
+0.40%Aug 7, 2026, 05:20 UTC
TriSalus reported a significant revenue miss and lowered its guidance during Q2 2026, citing a Salesforce reorganization and delayed FDA review of its next-generation device.
Source:Aug 6, 2026, 20:05 UTC
TriSalus Life Sciences announced its financial results for the quarter ended June 30, 2026, reporting year-over-year and sequential growth.